The claim
“Boron does nothing — which is why you won’t find it in most supplements.”
The argument is often used to dismiss boron as an irrelevant trace element not worth including in any formulation.
What the evidence actually shows
Vitamin D metabolism
Boron appears to influence the activity of 25-hydroxylase and 1α-hydroxylase, the enzymes involved in activating vitamin D. Several studies report elevated 25-OH-D levels with boron supplementation. This is mechanistically plausible given boron’s interactions with steroid hormone enzymes.
Hormones
Small RCTs report modestly elevated testosterone and DHEA-S values alongside reduced SHBG levels following boron supplementation. These are preliminary findings from limited trials — they suggest a signal, not a robust proven effect.
Bone and inflammation
Animal and human studies indicate effects on bone formation markers and reductions in inflammatory markers such as CRP and TNF-α. The bone-related effects are consistent with boron’s influence on calcium and magnesium metabolism.
Dietary context
Major dietary sources include nuts, legumes, and avocados. Low-carbohydrate diets or heavily processed diets can lead to low boron intake, which may be relevant in practice.
EFSA and BfR status
- EFSA: Boron is not defined as an essential trace element and has no approved EU health claims. Tolerable upper intake levels exist, which implies it is pharmacologically active at higher doses — the opposite of “no effect”.
- BfR: Focuses primarily on safety limits rather than positive effects. This regulatory caution does not imply that boron is inert.
Verdict
This claim is exaggerated. Boron is not officially essential, but the growing evidence for hormonal, bone-related, and vitamin D-modulating effects contradicts the assertion that it is meaningless. The absence of approved EU health claims reflects the evidentiary bar for regulatory approval, not a scientific consensus that boron is without physiological relevance.